I met with Maryellen Ariel Evans last week. She was in Israel on vacation and we had coffee on the Bat Yam boardwalk. Maryellen is a serial entrepreneur; her latest venture is a security product for IBM Websphere MQ Series. She’s passionate about message queue security and I confess to buying into the vision.
She has correctly put her finger on a huge, unmitigated threat surface of transactions that are transported inside the business and between business units using message queuing technology. Message queuing is a cornerstone of B2B commerce and in a highly interconnected system, there are lots of entry points all using similar or same technology – MQ Series or the TIB.
While organizations are busy optimizing their firewalls and load balancers, attackers can tap in, steal the data on the message bus and use it as a springboard to launch new attacks. It is conceivable that well placed attacks on message queues in an intermediary player (for example a payment clearing house) could result in the inability of the processor to clear transactions but also serve as an entry point into upstream and downstream systems. A highly connected stem of networked message queues is a convenient and vulnerable entry point from which to launch attacks; these attacks can and do cascade.
If these attacks cascade, the entire financial system could crash.
Although most customers are still fixated on perimeter security, I believe that Maryellen has a powerful value proposition for message queuing customers in the supply chains of key industries that rely on message interchange: banking, credit cards, health care and energy.

CLINICAL TRIAL READINESS ASSESSMENT
Are you really ready to run a clinical trial? How can you best assess your clinical trial readiness? We work with C-level executives and management